Intrahospital Transport in Patients With High-flow Nasal Oxygenation: Prospective Observational Study
- Conditions
- Critical Illness
- Registration Number
- NCT05311007
- Lead Sponsor
- Centre Hospitalier R茅gional d'Orl茅ans
- Brief Summary
High-flow nasal oxygen therapy is commonly used in intensive care unit (ICU). Intra-hospital transfer of critical patients is frequent: 1) to perform diagnostic 2) between emergency room or medical wards and ICU. During theses transfers, oxygenation should be continued.
There is high-flow nasal oxygen therapy for transport using an external battery. This mode of operation in transport mode allows about 30-45 min of autonomy.
Intra-hospital transport under high-flow nasal oxygen therapy has been previously described on children.
The objective of this study is to evaluate the occurrence of complications during intra-hospital transports under high-flow nasal oxygen of critical patients.
- Detailed Description
High-flow nasal oxygen therapy is commonly used in intensive care unit (ICU). Intra-hospital transfer of critical patients is frequent: 1) to perform diagnostic 2) between emergency room or medical wards and ICU. During theses transfers, oxygenation should be continued.
There is high-flow nasal oxygen therapy for transport using an external battery. This mode of operation in transport mode allows about 30-45 min of autonomy.
Intra-hospital transport under high-flow nasal oxygen therapy has been previously described on children.
The objective of this study is to evaluate the occurrence of complications during intra-hospital transports under high-flow nasal oxygen of critical patients.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 175
- Patient treated with high-flow nasal oxygen therapy before the intra-hospital transport prior to transport
- Requiring an intra-hospital transport (e.g., CT scan, OR, etc.) or inter-departmental transport supervised by the ICU team
Nb: Once the patient is included in the study, any intra-hospital transport under high-flow nasal oxygen therapy will be analyzed until discharge from the intensive care unit and at until D28.
- Under 18 years old
- Patient being under guardianship, tutorship or curatorship
- Pregnancy or breastfeeding
- Lack of social security number
- Refusal to participate in the study
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of severe adverse events during intra-hospital transport Up to 28 days To evaluate the incidence of severe adverse events during intra-hospital transport of patients treated with high-flow nasal oxygen surpervised by an ICU staff.
Severe adverse event is defined by the occurrence of intubation during transport or severe hypoxemia defined as pulse oxygen saturation (SpO2 \< 80%) or cardiorespiratory arrest.
- Secondary Outcome Measures
Name Time Method Incidence of minor adverse events during intra-hospital transport Up to 28 days To evaluate the incidence of minor adverse events during intra-hospital transport of patients treated with high-flow nasal oxygen surpervised by an ICU staff.
Minor adverse event is defined by the occurrence of the need to increase the FiO2 or a pull-out of nasal cannulas or the use of an alternative mode of oxygenation (standard oxygen or noninvasive ventilation) or a failure of high-flow nasal oxygenation system (ie battery failure)
Trial Locations
- Locations (4)
Hospital Center of DAX
馃嚝馃嚪DAX, France
CH de Martigues
馃嚝馃嚪Martigues, France
CHR d'ORLEANS
馃嚝馃嚪Orl茅ans, France
CH Bretagne Atlantique vannes-Auray
馃嚝馃嚪Vannes, France